Deal-Making
Resilience in risk-sharing gene therapy partnership with BridgeBio
Deal MakingResilience in risk-sharing gene therapy partnership with BridgeBioResilience in risk-sharing gene therapy partnership with BridgeBio
National Resilience has teamed up with BridgeBio to develop two investigational gene therapies to remedy Canavan disease and CAH.